IDEX Corporation, based in Northbrook, Illinois, specializes in fluid and metering technologies, health and science technologies, and fire, safety, and other products. With a market cap of $12.3 billion, IDEX operates in the Americas, Europe, and the Indo-Pacific.

IDEX is set to release its Q3 results on Oct. 29, with analysts expecting an adjusted profit of $1.93 per share, a 1.6% increase from the year-ago quarter. The company has consistently exceeded Wall Street’s projections in the last four quarters.

Analysts forecast IDEX to report an adjusted EPS of $7.89 for fiscal 2025, remaining flat year-over-year. In fiscal 2026, earnings are expected to grow by 8.4% to $8.55 per share.

IEX stock prices have dropped by 21.6% over the past 52 weeks, underperforming compared to the Industrial Select Sector SPDR Fund’s 8.9% gains and the S&P 500 Index’s 13.5% returns during the same period.

Despite surpassing expectations, IDEX’s stock prices fell by 11.3% following the release of its Q2 results on Jul. 30. The company achieved record sales with net sales of $865.4 million, up 7.2% year-over-year, and an adjusted EPS of $2.07. However, the full-year guidance did not meet expectations, leading to a sell-off.

Analysts hold a cautiously optimistic view on IEX stock, with a consensus “Moderate Buy” rating. Of the 13 analysts covering the stock, there are six “Strong Buys,” one “Moderate Buy,” and six “Holds.” The mean price target of $192.64 suggests a 16.7% upside potential from current levels.

Read more at Yahoo Finance: IDEX Earnings Preview: What to Expect